Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,749 | -5,272 | -13,676 | -9,925 | -6,866 |
| Depreciation Amortization | -418 | -198 | 14 | 137 | 172 |
| Accounts receivable | -106 | 25 | 48 | 55 | 42 |
| Other Working Capital | -788 | -58 | 585 | -95 | -394 |
| Other Operating Activity | 942 | 414 | 1,518 | 1,083 | 662 |
| Operating Cash Flow | $-10,119 | $-5,089 | $-11,511 | $-8,745 | $-6,384 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -25,608 | 2,516 | 11,619 | 6,863 | 4,748 |
| PPE Investments | -11 | -7 | -81 | -49 | -6 |
| Investing Cash Flow | $-25,619 | $2,509 | $11,538 | $6,814 | $4,742 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3 | -1 | -6 | -5 | -3 |
| Common Stock Issued | 36,852 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $36,849 | $-1 | $-6 | $-5 | $-3 |
| Beginning Cash Position | 4,728 | 4,728 | 4,707 | 4,707 | 4,707 |
| End Cash Position | 5,839 | 2,147 | 4,728 | 2,771 | 3,062 |
| Net Cash Flow | $1,111 | $-2,581 | $21 | $-1,936 | $-1,645 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,119 | -5,089 | -11,511 | -8,745 | -6,384 |
| Capital Expenditure | -11 | -7 | -81 | -49 | -6 |
| Free Cash Flow | -10,130 | -5,096 | -11,592 | -8,794 | -6,390 |